Back to Search

JOSHUA SCHUELLER, MD

MD

Obstetrics & Gynecology Physician

NPI: 1518696285Individual

Specialties, Licenses & Credentials

Obstetrics & Gynecology PhysicianPrimary

Obstetrics & Gynecology

Code: 207V00000X

77134(TN)

Research & Publications (9)

Systemic bevacizumab (Avastin) therapy for exudative neovascular age-related macular degeneration. The BEAT-AMD-Study.
PMID 19406737·Br J Ophthalmol·2009
2-rct
HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancer.
PMID 19383888·Cancer Epidemiol Biomarkers Prev·2009
8-other
Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer.
PMID 18398148·J Clin Oncol·2008
3-trial
Regulation of genes of the circadian clock in human colon cancer: reduced period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors.
PMID 17699798·Cancer Res·2007
8-other
Differential diagnosis of benign and malign pancreatic masses with 18F-fluordeoxyglucose-positron emission tomography recorded with a dual-head coincidence gamma camera.
PMID 17489057·Eur J Gastroenterol Hepatol·2007
8-other
Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment of Cancer Chronotherapy Group.
PMID 16877722·J Clin Oncol·2006
3-trial
Pharmacokinetics of darbepoetin alfa after intravenous or subcutaneous administration in patients with non-myeloid malignancies undergoing chemotherapy.
PMID 16485917·Clin Pharmacokinet·2006
3-trial
Pharmacokinetics of gemcitabine combined with trastuzumab in patients with advanced breast cancer.
PMID 15933419·Onkologie·2005
3-trial
A double-blind, randomised, parallel study comparing intravenous dolasetron plus dexamethasone and intravenous dolasetron alone for the management of fractionated cisplatin-related nausea and vomiting.
PMID 10650898·Support Care Cancer·2000
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Via practice · 2 locations total

Address
929 SPRING CREEK RD STE 102
CHATTANOOGA, TN 37412

Locations (2)

Practice Location

929 SPRING CREEK RD STE 102, CHATTANOOGA, TN
(423) 629-9743

Practice Location

301 UNIVERSITY BLVD, GALVESTON, TX
(409) 747-4952

Quick Facts

NPI
1518696285
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
2
Publications
9

Are you this provider?

Claim Your Profile